Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder

Summary

This human laboratory study aims to assess the effects of cannabidiol on alcohol consumption and craving in participants with alcohol use disorder. In this double-blind within-subject placebo-controlled crossover trial, participants will be randomized to receive both cannabidiol and placebo with a 2-week washout period separating the two treatment phases.

Timeline

Start

2024-08-16

Primary completion

2026-06-30

Completion

2026-06-30

Drugs

Indications